ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Quadruple Valve Replacement for Carcinoid Heart Disease
Clark S, Sundararaaja Ravikumar M, Mutjeba S, et al. Quadruple Valve Replacement for Carcinoid Heart Disease. November 2024. doi:10.25373/ctsnet.27902466
This video is part of CTSNet’s 2024 Innovation Video Competition. Watch all entries into the competition, including the winning videos.
The authors demonstrate a quadruple valve replacement in a patient with carcinoid heart disease causing severe regurgitation of all four heart valves and poor left ventricular (LV) function. To date, only 11 quadruple valve replacements have been performed in the United Kingdom, and 85 percent of UK units have no experience with this operation. This case is one of four successful cases undertaken in the surgeons’ unit in the last five years. It is the world’s first use of the Edwards Mitris Resilia valve in the tricuspid position and the world’s first use of Edwards Resilia valves in all four positions.
The authors demonstrate the techniques used, including patch augmentation of the right ventricular outflow tract (RVOT) to facilitate pulmonary valve implantation. The operation was successful, and the patient is now home in NYHA class I.
References
- Bhattacharyya S, Davar J, Dreyfus G, Caplin ME. Carcinoid heart disease. Circulation. 2007 Dec 11;116(24):2860-5. doi: 10.1161/CIRCULATIONAHA.107.701367. PMID: 18071089.
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
Printer-friendly
